Table 4.
Development cohort (n = 4280) | |||||
| |||||
Score cutoff (greater than or equal to) | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | No. of patients with score less than cutoff |
| |||||
0 | 100 | 0 | 63 | — | 0 |
1 | 99 | 5 | 65 | 79 | 107 |
2 | 97 | 11 | 65 | 70 | 243 |
3 | 92 | 24 | 68 | 64 | 581 |
4 | 84 | 41 | 71 | 60 | 1072 |
5 | 76 | 53 | 74 | 56 | 1477 |
6 | 63 | 69 | 78 | 52 | 2091 |
7 | 54 | 75 | 79 | 48 | 2435 |
8 | 38 | 86 | 83 | 45 | 3024 |
9 | 31 | 90 | 84 | 43 | 3288 |
10 | 18 | 95 | 86 | 40 | 3724 |
11 | 16 | 96 | 87 | 40 | 3793 |
12 | 13 | 97 | 88 | 39 | 3891 |
13 | 9 | 98 | 87 | 38 | 3996 |
14 | 2 | 99 | 84 | 37 | 4212 |
15 | 1 | 99 | 80 | 37 | 4240 |
| |||||
Validation cohort (n = 2844) | |||||
| |||||
Score cutoff (greater than or equal to) | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | No. of patients with score less than cutoff |
| |||||
0 | 100 | 0 | 64 | — | 0 |
1 | 99 | 3 | 64 | 72 | 47 |
2 | 98 | 9 | 66 | 72 | 127 |
3 | 93 | 22 | 68 | 65 | 349 |
4 | 86 | 44 | 73 | 64 | 713 |
5 | 78 | 55 | 75 | 58 | 970 |
6 | 63 | 71 | 79 | 52 | 1399 |
7 | 55 | 76 | 80 | 49 | 1600 |
8 | 40 | 87 | 85 | 45 | 1976 |
9 | 32 | 91 | 86 | 43 | 2165 |
10 | 18 | 96 | 89 | 40 | 2483 |
11 | 16 | 96 | 89 | 39 | 2515 |
12 | 13 | 98 | 92 | 39 | 2584 |
13 | 10 | 99 | 93 | 38 | 2656 |
14 | 3 | 100 | 93 | 37 | 2783 |
15 | 2 | 100 | 92 | 36 | 2807 |
Abbreviations: NPV, negative predictive value; PPV, positive predictive value.